BQ_-_14_-_Summer_2014

CONNECTING
THE COMMUNITY
Navigating the payer
landscape shouldn’t be
a leap of faith.
© 2014 EYGM Limited. All Rights Reserved. ED 0814
Cristal Thomas, deputy governor of Illinois, John Conrad from iBIO,
Nancy Sullivan from IllinoisVentures and John Pletz from Crain’s
Chicago Business (L to R).
Jeff Malehorn from World Business Chicago gave a presentation
on Chicago’s global status during the lunch panel covering
international issues.
EY’s 10th annual pharmaceutical
industry report, Progressions 2014:
navigating the payer landscape, is
the latest installment in a story we’ve
been writing about for the last five
years. The report, available April 29,
addresses how the move to value-driven
outcomes and the democratizing power
of big data and mHealth technologies
are fundamentally disrupting the
pharmaceutical industry’s business model.
Progressions 2014 contains insights from
and interviews with more than 30 industry
leaders, representing a broad array of
stakeholders from across the health
care ecosystem: payers, providers, data
and analytics companies, policymakers,
pharma and more.
Visit ey.com/lifesciences.
John Pletz from Crain’s Chicago Business (far left) moderates the closing panel, Chicago’s Life Sciences Startup Ecosystem, with Illinois Department of
Commerce and Economic Opportunity (DCEO) Director Adam Pollet, Norbert Riedel from Naurex, Nancy Sullivan from IllinoisVENTURES,
Michael Liang from Baird, and Tim Walbert from Horizon Pharma (L to R).
44 45
BioLogical Quarterly Summer 2014